학술논문
EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization
Document Type
Article
Author
Source
In: Journal of Hepatology . (Journal of Hepatology, December 2011, 55(6):1309-1316)
Subject
Language
English
ISSN
01688278